Overview
Psilocybin has been investigated for the treatment of Anxiety and Stage IV Melanoma. In November, 2019, it was granted Breakthrough Therapy status by the FDA.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2025/07/14 | Not Applicable | Not yet recruiting | Bruyère Health Research Institute. | ||
2025/07/08 | Not Applicable | Not yet recruiting | |||
2025/07/03 | Not Applicable | Not yet recruiting | MycoMedica Life Sciences PBC | ||
2025/07/02 | Not Applicable | Not yet recruiting | |||
2025/05/28 | Phase 1 | Not yet recruiting | Francisco A Moreno | ||
2025/05/25 | Phase 1 | Not yet recruiting | |||
2025/05/23 | Phase 1 | Not yet recruiting | |||
2025/05/13 | Phase 2 | Recruiting | |||
2025/04/09 | Phase 1 | ENROLLING_BY_INVITATION | Joshua Woolley, MD, PhD | ||
2025/03/30 | Phase 2 | Not yet recruiting | Sunstone Medical |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.